Expression and regulation of transforming growth factor β1 in cultured normal and neoplastic rat pituitary cells

Endocrine Pathology

Volumn 7, Issue 1, 1996, Pages 77-90

  Qian, Xiang ^a   Jin, Long ^a   Lloyd, Ricardo V ^a  

^a MAYO CLINIC   (United States)

Author keywords

Basic fibroblast growth factor (bFGF); Cell culture; Estradiol 17 (E2); Pituitary; Transforming growth factor beta (TGF )

Indexed keywords

EID: 0002681980     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02739918     Document Type: Article

References (50)

1. Furth J, Ueda G, Clifton KH. The pathophysiology of pituitaries and their tumors: methodological advances. Methods Cancer Res 10:210-277, 1973.
2. Murdoch GH, Potter E, Nicolaisen AK, Evans RM, Rosenfeld MG. Epidermal growth factor rapidly stimulates prolactin gene transcription. Nature 300:192-194, 1982.
3. Castrillo J-L, Bodner M, Karin M. Purification of growth hormone specific transcription factor GHF-1, containing homeobox. Science 243:814-817, 1989.
4. Simmons PM, Voss JW, Ingraham HA, Hollowy JM, Groide RS, Rosenfled MG, Swanson LW. Pituitary cell phenotype involve cell specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Gen Dev 4:695-711, 1990.
5. 3 cells. Proc Soc Expt Biol Med 202:193-200, 1993.
6. Wiklund J, Wertz N, Gorski J. A comparison of estrogen effects on uterine and pituitary growth and prolactin synthesis in F344 and Holtzman rats. Endocrinology 109:1700-1707, 1981.
7. Lloyd RV. Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland: an immunohistochemical study. Am J Pathol 113:198-206, 1983.
8. Lloyd RV, Cano M, Landefeld TD. The effects of estrogens on tumor growth and on prolactin and growth hormone in mRNA expression in rat pituitary tissues. Am J Pathol 133, 397-406, 1988.
9. 3 cells. Mol Endocrinol 5:1716-1722, 1991.
10. Mueller SG, Kudlow JE. Transforming growth factor-β (TGFβ) inhibitsTGFα expression in bovine anterior pituitary-derived cells. Mol Endocrinol 5:1439-1446, 1991.
11. Albaladejo V, Fei ZL, Nicholas B, Joly-Pharaboz MO, Avallet O, Vigier M, Andre J. Possible involvement of transforming growth factor-β in the inhibition of rat pituitary tumor growth by estradiol. J Steroid Biochem Mol Biol 41:125-134, 1992.
12. 4 pituitary cell proliferation. Endocrinology 128:1981-1990, 1991.
13. Sarkar DK, Kim KH, Minami S. Transforming growth factor-β1 messenger RNA and protein expression in the pituitary gland: its action on prolactin secretion and lactotropic growth. Mol Endocrinol 6:1825-1833, 1992.
14. Burns G, Sarkar DK. Transforming growth factor-β1-like immunoreactivity in the pituitary gland of the rat: effect of estrogen. Endocrinology 133:1444-1449, 1993.
15. Sporn MB, Roberts AB, Wakefield LM, de Crombrugghe B. Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol 105:1039-1045, 1987.
16. Moses HL, Yang EY, Pietenpol JA. TGF-β stimulation and inhibition of cell proliferation: new mechanistic insights. Cell 63:245-247, 1990.
17. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB. Evidence that transforming growth factor-beta is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48:417-428, 1987.
18. Baird A, Bohlen P. Fibroblast growth factors. In: Sporn MB, Roberts AB, eds. Peptide growth factors. New York: Springer-Verlag, 1990;369-417.
19. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G. Structural characterization and biological functions of fibroblast growth factor. Endocrine Rev 8:95-114, 1987.
20. Larson GH, Koos RD, Sortino MA, Wise PM. Acute effect of basic fibroblast growth factor on secretion of prolactin as assessed by the reverse hemolytic plaque assay. Endocrinology 126:927-932, 1990.
21. Schecter J, Weiner R. Changes in basic fibroblast growth factor coincident with estradiolinduced hyperplasia of the anterior pituitaries of Fischer 344 and Sprague-Dawley rats. Endocrinology 129:2400-2408, 1991.
22. Porter TE, Wiles CD, Frawley LS. Stimulation of lactotrope differentiation in vitro by fibroblast growth factor. Endocrinology 134:164-168, 1994.
23. Gonzalez AM, Logan A, Ying W, Lappri DA, Berry M, Baird A. Fibroblast growth factor in the hypothalamic-pituitary axis: differential expression of fibroblast growth factor-2 and a high affinity receptor. Endocrinology 134: 2289-2297, 1994.
24. Tashijian AH Jr, Yasumura Y, Levine L, Sato GH, Parker ML. Establishment of clonal strains of rat pituitary tumor cells that secrete growth hormone. Endocrinology 82:342-352, 1968.
25. Lloyd RV, Coleman K, Fields K, Nath V. Analysis of prolactin and growth hormone production in hyperplastic and neoplastic rat pituitary tissue by the hemolytic plaque assay. Cancer Res 47:1087-1092, 1987.
26. Lloyd RV, Landefeld TD, Maslar I, Frohman LA. Diethylstilbestrol inhibits tumor growth and prolactin production in rat pituitary tumors. Am J Pathol 118:379-386, 1985.
27. Cooke NE, Coit D, Weiner RI, Baxter JD, Martial JA. Structure of clonal DNA complementary to rat prolactin messenger RNA. J Biol Chem 255:6502-6510, 1980.
28. Seeburg PH, Shine J, Martial JA, Baxter JD, Goodman HM. Nucleotide sequence and amplification in bacterial of structure gene for rat growth hormone. Nature 270:486-494, 1977.
29. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
30. Qian SW, Kondaiah P, Roberts AB, Sporn MB. cDNA cloning by PCR of rat transforming growth factor beta 1. Nucleic Acids Res 18:3059, 1990.
31. Miller DA, Lee A, Pelton RW, Chen EY, Moses HL, Derynck R. Murine transforming growth factor-beta 2 cDNA sequence and expression in adult tissues and embryos. Mol Endocrinol 3:1108-1114, 1989.
32. Miller DA, Lee A, Matsui Y, Chen EY, Moses HL, Derynck R. Complementary DNA cloning of the murine transforming growth factor-beta-3 (TGF-beta-3) precursor and the comparative expression of TGF-beta-3 and TGF-beta-1 messenger RNA in murine embryos and adult tissues. Mol Endocrinol 3:1926-1934, 1989.
33. Ebner R, Chen H, Shum L, Lawler S, Lee AL, Zioncheck TF, Lopez AR, Derynck R. Cloning of a type I TGF-beta receptor and its effect on TFG-beta binding to the type II receptor. Science 260:1334-1348, 1993.
34. Choi ME, Kim EG, Huang Q, Ballermann BJ. Rat mesengial cell hypertrophy in response to transforming growth factor-beta 1. Kidney Int 44:948-958, 1993.
35. Wang X-F, Lin HY, Ng-Eaton E, Downward J, Lodish HF, Weinberg RA. Expression cloning and characterization of the TFG-beta type III receptor. Cell 67:797-805, 1991.
36. Fields K, Kulig E, Lloyd RV. Detection of prolactin messenger RNA in mammary and other normal and neoplastic tissue by polymerase chain reaction. Lab Invest 68:354-360, 1993.
37. Gerdes J, Becker MH, Key G, Cattoretti G. Immunohistochemical detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 168:85,86, 1992.
38. Waseem NH, Lane DP. Monoclonal antibody analysis of the proliferating cell nuclear antigen structural conservation and the detection of a nucleolar form. J Cell Sci 96:121-129, 1990.
39. Attisano L, Wrana JL, Lopez-Casillas F, Massague J. TGF-β receptors and actions. Biochem Biophys Acta 1222:71-80, 1994.
40. Freiss H, Yamanaka Y, Buchler M, Berger HG, Kobrin MS, Baldwin RL, Korc M. Enhanced expression of the type II transforming growth factor β receptor in human pancreatic cancer cells without alteration of type III receptor expression. Cancer Res 53:2704-2707, 1993.
41. Park K, Kim S-J, Bang Y-J, Park J-G, Kim NK, Roberts AB, Sporn MB. Genetic changes in the transforming growth factor β (TGFβ) type II receptor gene in human gastric cancer cells: correlation with sensitivity to growth inhibition by TGFβ. Proc Natl Acad Sci USA 91:8772-8776, 1994.
42. 3 pituitary cells that recognizes transforming growth factor-β, activin and inhibin. J Biol Chem 263: 17,225-17,228, 1988.
43. 3) expresses type I and type II receptors and other cell surface binding proteins for transforming growth factor-β. J Biol Chem 270:770-774, 1995.
44. 3 pituitary tumor cells contain heteromeric type I and type II receptor complexes for transforming growth factor-β and activin-A. J Biol Chem 270:765-769, 1995.
45. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowsica E, Kinzler KW Vogelstein B, Brattain M, Wilson KV. Inactivation of the type II TGF-β receptor in colon cancer cells with microsatellite instability. Science 268:1336-1338, 1995.
46. Hunter T, Pines J. Cyclins and cancer II: cyclin D and CDK inhibitors come of age. Cell 79:573-582, 1994.
47. kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 78:59-66, 1994.
48. kip1, a cyclin-cdk inhibitor, links transforming growth factor-β and contact inhibition to cell cycle arrest. Genes Dev 8:9-22, 1994.
49. Toyoshima H, Hunter T. p27, a novel inhibitor of G1 cyclin-cdk protein kinase activity, is related to p21. Cell 78:67-74, 1994.
50. INK4B is a potential effector of TGFβ-induced cell cycle arrest. Nature 371:257-261, 1994.